Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mexican Biosimilar Filgrastim for Autologous Hematopoietic Stem Cell Mobilization and Transplantation

1 Jul 2016

Abstract excerpt

BACKGROUND: Following the release of the initial presentation of filgrastim (granulocyte colony-stimulating factor), several biosimilars have been developed worldwide. OBJECTIVE: To study the efficacy of a Mexican biosimilar granulocyte colony-stimulating factor in a single transplant center. METHODS: In a group of 19 consecutive patients with multiple sclerosis given autografts, we employed granulocyte...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biosimilars and Bioanalytical Methods
Share to Hematopoietic Stem Cell Transplantation
Share to Neutropenia and Cancer Infections

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27623036
DOI: 10.1016/s0034-8376(25)00274-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Mexican Biosimilar Filgrastim for Autologous Hematopoietic Stem Cell Mobilization and TransplantationPMID 27623036Read ↗

Hematopoietic Stem Cell Transplantation in People With Active Secondary Progressive Multiple SclerosisSemantic proximity Read ↗

Cannabis use and its relationship with mobilization efficiency, hematological recovery and neurologic response after hematopoietic stem cell transplantation in patients with multiple sclerosis: A single center, eight-year experienceSemantic proximity Read ↗

Sustained remission in multiple sclerosis after hematopoietic stem cell transplantationSemantic proximity Read ↗

Characterization and comparability of biosimilars: A filgrastim case of study and regulatory perspectives for Latin AmericaSemantic proximity Read ↗

Clinical outcomes after autologous haematopoietic stem cell transplantation in patients with progressive multiple sclerosisSemantic proximity Read ↗

Immune Reconstitution Following Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: A Review on Behalf of the EBMT Autoimmune Diseases Working Party.Semantic proximity Read ↗

Safety and efficacy of stem cell therapy for treatment of neural damage in patients with multiple sclerosisSemantic proximity Read ↗

Mesenchymal stem cells—the master immunomodulatorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.